CCT3 and oral cavity carcinoma: According to Pyeon’s study [40], CCT3 was overexpressed, compared with those in the normal samples in all of the HNSC types: tonsillar carcinoma with a fold change of 2.534, oral cavity carcinoma with a fold change of 3.115, floor of the mouth carcinoma with a fold change of 3.68, oropharyngeal carcinoma with a fold change of 3.001, and tongue carcinoma with a fold change of 2.529 (Table 1).